These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8545398)

  • 1. [Expansive uterine myoma during tamoxifen therapy. 11 cases].
    Le Bouëdec G; de Latour M; Dauplat J
    Presse Med; 1995 Nov; 24(36):1694-6. PubMed ID: 8545398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitotically active leiomyoma of the uterus in a postmenopausal breast cancer patient receiving tamoxifen.
    Liu IF; Yen YS; Cheng YM; Chou CY
    Taiwan J Obstet Gynecol; 2006 Jun; 45(2):167-9. PubMed ID: 17197361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen-induced growth of leiomyomas. A case report.
    Kang J; Baxi L; Heller D
    J Reprod Med; 1996 Feb; 41(2):119-20. PubMed ID: 8656411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Uterine pathology in women with breast cancer treated with tamoxifen].
    Carcangiu ML
    Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
    [No Abstract]   [Full Text] [Related]  

  • 5. [Uterine sarcoma in patients receiving tamoxifen therapy. Apropos of 2 cases].
    Le Bouëdec G; Auvray H; Curé H; de Latour M; Penault-Llorca F; Dauplat J
    Rev Med Interne; 2001 Sep; 22(9):881-5. PubMed ID: 11599191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tamoxifen and endometrial pathology].
    Negoiţă M; Terinte C; Mihailovici MS
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid growth of leiomyoma in patient receiving tamoxifen.
    Dilts PV; Hopkins MP; Chang AE; Cody RL
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):167-8. PubMed ID: 1733191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Micro-metastases into the uterine leiomyoma from invasive ductal breast cancer under adjuvant tamoxifen therapy: case report.
    Dirican A; Kucukzeybek Y; Somali I; Erten C; Demir L; Can A; Bayoglu IV; Yigit SC; Unay FC; Yetimalar MH; Tarhan MO
    Eur J Gynaecol Oncol; 2012; 33(6):652-5. PubMed ID: 23327065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal uterine bleeding as a presenting sign of metastases to the uterine corpus, cervix and vagina in a breast cancer patient on tamoxifen therapy.
    Piura B; Yanai-Inbar I; Rabinovich A; Zalmanov S; Goldstein J
    Eur J Obstet Gynecol Reprod Biol; 1999 Mar; 83(1):57-61. PubMed ID: 10221611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent tamoxifen-related Müllerian adenofibromas in uterus and ovary.
    Shi H; Chen X; Lv B; Zhang X
    Int J Clin Exp Pathol; 2015; 8(11):15381-5. PubMed ID: 26823898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine metastases from breast cancer in a patient under tamoxifen therapy. Case report.
    Dessole S; Cherchi PL; Ruiu GA; Meloni GB; Cossu Rocca P
    Eur J Gynaecol Oncol; 1999; 20(5-6):416-7. PubMed ID: 10609509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One step forward or one step back with tamoxifen?
    Gelmon K
    Lancet; 2000 Sep; 356(9233):868-9. PubMed ID: 11036885
    [No Abstract]   [Full Text] [Related]  

  • 13. Müllerian adenosarcoma of the uterus with sarcomatous overgrowth following tamoxifen treatment for breast cancer.
    Carvalho FM; Carvalho JP; Motta EV; Souen J
    Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(1):17-20. PubMed ID: 10881074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-grade endometrial stromal sarcoma after tamoxifen therapy for breast cancer.
    Sesti F; Patrizi L; Ermini B; Palmieri G; Orlandi A; Piccione E
    Gynecol Obstet Invest; 2005; 60(2):117-20. PubMed ID: 15920338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine leiomyomata and endometrial proliferation in postmenopausal women treated with the anti-oestrogen tamoxifen.
    Ugwumadu AH; Harding K
    Eur J Obstet Gynecol Reprod Biol; 1994 Apr; 54(2):153-6. PubMed ID: 8070603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Explosive growth of uterine leiomyomas and carcinologic ovarian risk in a non-menopausal patient with BRCA1-BRCA2 mutation treated by tamoxifen].
    Doridot V; This P; Clough KB
    J Gynecol Obstet Biol Reprod (Paris); 2002 Nov; 31(7):677-80. PubMed ID: 12457141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant mixed Mullerian tumour of uterus secondary to tamoxifen therapy for hormone responsive breast cancer.
    Gupta M; Kiruthiga KG
    BMJ Case Rep; 2015 Jun; 2015():. PubMed ID: 26123463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [MR Imaging of the pelvis in the diagnosis of the endometrium in breast cancer patients in tamoxifen therapy].
    Hauth E; Libera H; Kimmig R; Forsting M
    Rofo; 2006 Mar; 178(3):316-23. PubMed ID: 16508840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging findings of tamoxifen-associated uterine Müllerian adenosarcoma: a case report.
    Soh E; Eleti A; Jimenez-Linan M; Arends MJ; Latimer J; Sala E
    Acta Radiol; 2008 Sep; 49(7):848-51. PubMed ID: 19143068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.